Navigation Links
Odyssey Thera Announces U.S. Patent for Technologies Enabling Protein Interaction Screening and Directed Evolution
Date:1/5/2011

SAN RAMON, Calif., Jan. 5, 2011 /PRNewswire/ -- Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167.  The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays (PCA).  The patent, the eighteenth assigned to Odyssey Thera, further protects assays utilizing fragments of inherently fluorescent proteins, and the use of these assays for high-throughput screening of defined panels of proteins.  The strategy is applicable in any cell type and using a wide range of reporters and detection methods.  The invention enables identification and validation of genes and proteins involved in any cellular process, and also provides assays to study the effects drugs and gene expression or knockout on specific pathways.

"This patent significantly extends the reach of Odyssey Thera's technology platform," said John K. Westwick, Ph.D., Odyssey Thera President and CEO.  "The assays and their use in gene vs. library and library vs. library screening provide a uniquely powerful strategy for biotherapeutic identification and optimization, diagnostic and biomarker development, the discovery of genetic modifiers of animal and plant cell traits, and bioprocess engineering."

About Odyssey Thera

Odyssey Thera, Inc. is a technology company committed to developing breakthroughs in cellular analysis and engineering.  Odyssey Thera's technologies measure pathway activity within living cells, and are applicable to therapeutic discovery and development, engineering of any cell type or species, live animal imaging, and diagnostic and bioprocess applications.  To learn more about Odyssey Thera, please visit www.odysseythera.com.


'/>"/>
SOURCE Odyssey Thera, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Odyssey Thera to Participate in Expanded EPA Initiative
2. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
3. Stereotaxis and Siemens Promote Integrated Odyssey(TM) Solutions
4. Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones
5. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
6. DJO Incorporated Acquires Manufacturer of Compression Therapy Products, Elastic Therapy, Inc.
7. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
8. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
9. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
10. Graymark Healthcares Sleep Apnea Therapy Program Services Record Number of Patients in Q4 2010
11. Medco Extends URAC Accreditation to Drug Therapy Management, PBM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... , April 28, 2016  ValGenesis, ... Lifecycle Management Solutions (VLMS) today announced that ... services for sufferers of chronic kidney failure ... to manage their corporate validation process. The ... a software solution to manage their validation ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
Breaking Medicine Technology:
(Date:5/3/2016)... Fremont, California (PRWEB) , ... ... ... the leading provider of Microsoft secure remote access connectivity solutions, today announced ... deployed platform for Microsoft DirectAccess. The new Celestix SecureAccess release will enable ...
(Date:5/3/2016)... ... , ... Hydra Skin Sciences, a top-rated skincare company based in ... anti-aging skin care product that integrates Snow Algae Powder and six powerful ... thousand units worldwide within the first two months of release. , “We set out ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... helps healthcare organizations, especially medium and small physician practices, to better grasp and ... unique step-by-step approach that guides practices on a well-defined, expert-created path to compliance. ...
(Date:5/3/2016)... , ... May 03, 2016 ... ... Cruise Lines premiered the state-of-the-art Carnival Vista – the line’s largest cruise ... The Cruise Web has created an infographic spotlighting the Carnival Vista ...
(Date:5/2/2016)... ... May 03, 2016 , ... ... FDA approved sSOIP telemedicine stethoscope software that enables the stethoscope stream to go ... PCP-SSP and works with RNK’s flagship PCP-USB stethoscope. , Remote auscultation involves two ...
Breaking Medicine News(10 mins):